FR2264539A1 - Metformin orotate - hypoglycemic, hypocholesterolemic and uricosuric agent - Google Patents

Metformin orotate - hypoglycemic, hypocholesterolemic and uricosuric agent

Info

Publication number
FR2264539A1
FR2264539A1 FR7409962A FR7409962A FR2264539A1 FR 2264539 A1 FR2264539 A1 FR 2264539A1 FR 7409962 A FR7409962 A FR 7409962A FR 7409962 A FR7409962 A FR 7409962A FR 2264539 A1 FR2264539 A1 FR 2264539A1
Authority
FR
France
Prior art keywords
metformin
hypoglycemic
gout
hypocholesterolemic
orotate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7409962A
Other languages
English (en)
French (fr)
Other versions
FR2264539B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EXPL MARQUES BREVETS ET
Original Assignee
EXPL MARQUES BREVETS ET
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EXPL MARQUES BREVETS ET filed Critical EXPL MARQUES BREVETS ET
Priority to FR7409962A priority Critical patent/FR2264539A1/fr
Publication of FR2264539A1 publication Critical patent/FR2264539A1/fr
Application granted granted Critical
Publication of FR2264539B1 publication Critical patent/FR2264539B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7409962A 1974-03-22 1974-03-22 Metformin orotate - hypoglycemic, hypocholesterolemic and uricosuric agent Granted FR2264539A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7409962A FR2264539A1 (en) 1974-03-22 1974-03-22 Metformin orotate - hypoglycemic, hypocholesterolemic and uricosuric agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7409962A FR2264539A1 (en) 1974-03-22 1974-03-22 Metformin orotate - hypoglycemic, hypocholesterolemic and uricosuric agent

Publications (2)

Publication Number Publication Date
FR2264539A1 true FR2264539A1 (en) 1975-10-17
FR2264539B1 FR2264539B1 (de) 1977-11-04

Family

ID=9136731

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7409962A Granted FR2264539A1 (en) 1974-03-22 1974-03-22 Metformin orotate - hypoglycemic, hypocholesterolemic and uricosuric agent

Country Status (1)

Country Link
FR (1) FR2264539A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796551A1 (fr) * 1999-07-23 2001-01-26 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
FR2796940A1 (fr) * 1999-07-26 2001-02-02 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796551A1 (fr) * 1999-07-23 2001-01-26 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant
FR2796940A1 (fr) * 1999-07-26 2001-02-02 Lipha Nouveaux sels de metformine, leur procede d'obtention et les compositions pharmaceutiques en renfermant

Also Published As

Publication number Publication date
FR2264539B1 (de) 1977-11-04

Similar Documents

Publication Publication Date Title
JPS5590526A (en) Polyurethane resin and paint composition
ATE77557T1 (de) Zusammensetzung zur erhoehung der intrazell-atpspiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.
ATE31625T1 (de) Pharmazeutisches mittel zur behandlung des diabetes mellitus.
SE8201784L (sv) Lekemedel for behandling av sockersjuka
JPS56104815A (en) Remedy for peripheral orthostatic hypotension
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
ES8300104A1 (es) Un procedimiento para obtener derivados de benzopirano
FR2264539A1 (en) Metformin orotate - hypoglycemic, hypocholesterolemic and uricosuric agent
GB1386150A (en) 6-acylaminophenyl-4,5-dihydropyridazones
FR2230376A1 (en) Stable solutions of siloxanic polysilanols - prepd. by hydrolysis of a silane and having pharmaceutical activity
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
JPS54148090A (en) Peroral cholesterol-depressant
ATE85521T1 (de) Verwendung von acetyl-l-carnitin zur herstellung eines arzneimittels zur therapeutischen behandlung von schockzustaenden.
IL60161A0 (en) Guanidine derivatives,their production and pharmaceutical compositions containing them
JPS55122715A (en) Antidiabetic agent
FR2275199A1 (fr) (chloro-4 phenoxy) isobutyrate de dimethylbiguanide, son procede de preparation et medicaments contenant ce produit comme principe actif
RU2003338C1 (ru) Средство, обладающее желчегонным действием
JPS5675428A (en) Hypoglycemic agent containing procainamide hydrochloride
USD236268S (en) Best available copy
NL7703682A (en) Antiinflammatory, analgesic alclofenac lysine salt - with improved bio-availability and suitable for admin. by injection
USD205791S (en) Instrument face for gyroscopic instruments
JPS5398632A (en) Ball screw type steering apparatus
BE794239A (en) Caffeine dithiosalicylate - analgesic antipyretic and antiarrhythmic
JPS5339352A (en) Solution of polyurethane having good viscosity stability
JPS52108992A (en) Purification of cefalexin

Legal Events

Date Code Title Description
ST Notification of lapse